Cyclosporine-related encephalopathy following allogeneic bone marrow transplantation

International Journal of Hematology

Volumn 63, Issue 2, 1996, Pages 161-164

  Teshima, Takanori ^a   Miyoshi, Takeshi ^a   Ono, Minoru ^a  

^a KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

Author keywords

bone marrow transplantation; cyclosporine; thrombomodulin; thrombotic thrombocytopenic purpura

Indexed keywords

CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; THROMBOMODULIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BRAIN DISEASE; CASE REPORT; GRAFT REJECTION; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIC PURPURA;

EID: 0029864724     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(95)00431-9     Document Type: Article

References (15)

1. Atkinson K, Biggs J, Darveniza P, Roland J, Concannon A, Dodds A. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984;38:34-37.
2. Degroen PC, Aksamit AJ, Rakela J, Forbes GC, Krom RAF. Central nervous system toxicity after liver transplantation. N Engl J Med 1987;317:861-866.
3. Wilczek H, Ringden O, Tyden G. Cyclosporine-associated central nervous system toxicity after renal transplantation. Transplantation 1985;39:110.
4. Fiorani L, Bandini G, D'Alessandro R, Rosti G. Cyclosporine A neurotoxicity after allogeneic bone marrow trasnplantation. Bone Marrow Transplant 1994;14: 175-176.
5. Reece DE, Frei-Lahr DA, Shepherd JD et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991;8:393-401.
6. Van Buran D, Van Buran CT, Flechner SM, Maddox AM, Verani R, Kahan BD. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 1985;98:54-62.
7. Ishii H, Nagano M, Tubouchi J et al. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haematol 1990;63;157-162.
8. Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigaenemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994;86: 130-137.
9. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76:2024-2029.
10. Ikegami T, Oh H, Nakamura H et al. Serum thrombomodulin levels in patients receiving allogeneic bone marrow transplantation. Jpn J Clin Hematol 1993; 34; 773-775.
11. Yoshida M, Kozaki M, Ioya N et al. Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity. Transplantation 1990;50;1066-1069.
12. Zoja C, Furci L, Ghilardi F, Zillo P, Bernigni A, Remuzzi G. Cyclosporine-induced endothelial cell injury. Lab Invest 1986;55:455-462.
13. Powles RL, Morgenstern GR, Kay HEM et al. Mismatched family donors for bone marrow transplant as treatment for acute leukaemia. Lancet 1983;i:612-615.
14. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994;14:495-504.
15. Sloane JP, Lwin KY, Gore ME, Powles RL, Smoth JF. Disturbance of blood-brain barrier after bone marrow transplantation. Lancet 1985;ii:280.